Datatrak International has signed second global enterprise agreement, a three-year subscription license with a European pharmaceutical company encompassing a fixed volume of data items with an overall contract value worth a minimum of $800,000 to Datatrak.
Subscribe to our email newsletter
The total contract amount is a minimum value as Datatrak will be providing all associated services for this client’s global clinical trials utilizing Datatrak eClinical throughout the life of the subscription agreement. Additionally, optional components of the Datatrak eClinical Platform outside of the EDC (electronic data capture) or reporting (Data Genie) functionalities are contracted separately on an as needed basis for each project.
Jeffrey Green, president and CEO of Datatrak, said: “The consummation of two enterprise relationships within approximately the past two months indicates that there are companies looking at the benefits of a longer-term commitment for a standardized information platform to best serve their clinical trial needs.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.